Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation or Upfront Cranial RT in Oncogene Driver Mutated NSCLC With Asymptomatic Brain Metastases: A Phase III Randomized Controlled Trial

NCT05236946 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT05236946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation or Upfront Cranial RT in Oncogene Driver Mutated NSCLC With Asymptomatic Brain Metastases: A Phase III Randomized Controlled Trial
Lead sponsor
Tata Memorial Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
November 10, 2020
Completion date
December 31, 2026
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic brain metastases, driver mutation positive non-small cell lung cancer